111 related articles for article (PubMed ID: 34951690)
1. Evaluation of normal-appearing white matter with perfusion and diffusion MRI in patients with treated glioblastoma.
Şahin S; Ertekin E; Şahin T; Özsunar Y
MAGMA; 2022 Feb; 35(1):153-162. PubMed ID: 34951690
[TBL] [Abstract][Full Text] [Related]
2. A multi-reader comparison of normal-appearing white matter normalization techniques for perfusion and diffusion MRI in brain tumors.
Cho NS; Hagiwara A; Sanvito F; Ellingson BM
Neuroradiology; 2023 Mar; 65(3):559-568. PubMed ID: 36301349
[TBL] [Abstract][Full Text] [Related]
3. Comparison of ASL and DSC perfusion methods in the evaluation of response to treatment in patients with a history of treatment for malignant brain tumor.
Bayraktar ES; Duygulu G; Çetinoğlu YK; Gelal MF; Apaydın M; Ellidokuz H
BMC Med Imaging; 2024 Mar; 24(1):70. PubMed ID: 38519901
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Accuracy of Arterial Spin Labeling in Comparison With Dynamic Susceptibility Contrast-Enhanced Perfusion for Brain Tumor Surveillance at 3T MRI.
Lavrova A; Teunissen WHT; Warnert EAH; van den Bent M; Smits M
Front Oncol; 2022; 12():849657. PubMed ID: 35669426
[TBL] [Abstract][Full Text] [Related]
5. Diffusion magnetic resonance imaging of normal-appearing white matter in multiple sclerosis: correlation with brain volume and clinical disability.
Larassati H; Pandelaki J; Estiasari R; Prihartono J; Firdausia S; Yunus RE; Mulyadi R
J Cent Nerv Syst Dis; 2022; 14():11795735221098147. PubMed ID: 35572123
[TBL] [Abstract][Full Text] [Related]
6. Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas.
Cho NS; Sanvito F; Thakuria S; Wang C; Hagiwara A; Nagaraj R; Oshima S; Lopez Kolkovsky AL; Lu J; Raymond C; Liau LM; Everson RG; Patel KS; Kim W; Yang I; Bergsneider M; Nghiemphu PL; Lai A; Nathanson DA; Cloughesy TF; Ellingson BM
J Neurooncol; 2023 Jun; 163(2):417-427. PubMed ID: 37294422
[TBL] [Abstract][Full Text] [Related]
7. T1-Weighted Contrast Enhancement, Apparent Diffusion Coefficient, and Cerebral-Blood-Volume Changes after Glioblastoma Resection: MRI within 48 Hours vs. beyond 48 Hours.
Negroni D; Bono R; Soligo E; Longo V; Cossandi C; Carriero A; Stecco A
Tomography; 2023 Feb; 9(1):342-351. PubMed ID: 36828379
[TBL] [Abstract][Full Text] [Related]
8. Intracranial paragangliomas versus schwannomas: Role of dynamic susceptibility contrast perfusion and diffusion MRI.
Ota Y; Liao E; Capizzano AA; Baba A; Kurokawa R; Kurokawa M; Srinivasan A
J Neuroimaging; 2022 Sep; 32(5):875-883. PubMed ID: 35562184
[TBL] [Abstract][Full Text] [Related]
9. Decreased tissue stiffness in glioblastoma by MR elastography is associated with increased cerebral blood flow.
Fløgstad Svensson S; Fuster-Garcia E; Latysheva A; Fraser-Green J; Nordhøy W; Isam Darwish O; Thokle Hovden I; Holm S; Vik-Mo EO; Sinkus R; Eeg Emblem K
Eur J Radiol; 2022 Feb; 147():110136. PubMed ID: 35007982
[TBL] [Abstract][Full Text] [Related]
10. Dynamic susceptibility contrast perfusion-weighted and diffusion-weighted magnetic resonance imaging findings in pilocytic astrocytoma and H3.3 and H3.1 variant diffuse midline glioma, H3K27-altered.
Kurokawa R; Kurokawa M; Baba A; Kim J; Srinivasan A; Moritani T
PLoS One; 2023; 18(7):e0288412. PubMed ID: 37450487
[TBL] [Abstract][Full Text] [Related]
11. Dynamic susceptibility contrast and diffusion-weighted MRI in posterior fossa pilocytic astrocytoma and medulloblastoma.
Kurokawa R; Umemura Y; Capizzano A; Kurokawa M; Baba A; Holmes A; Kim J; Ota Y; Srinivasan A; Moritani T
J Neuroimaging; 2022 May; 32(3):511-520. PubMed ID: 34997668
[TBL] [Abstract][Full Text] [Related]
12. Comparative study between dynamic susceptibility contrast magnetic resonance imaging and arterial spin labelling perfusion in differentiating low-grade from high-grade brain tumours.
Patil V; Malik R; Sarawagi R
Pol J Radiol; 2023; 88():e521-e528. PubMed ID: 38125817
[TBL] [Abstract][Full Text] [Related]
13. Perfusion and diffusion-weighted imaging parameters: Comparison between pre- and postbiopsy MRI for high-grade glioma.
Kurokawa R; Baba A; Kurokawa M; Capizzano A; Ota Y; Kim J; Srinivasan A; Moritani T
Medicine (Baltimore); 2022 Sep; 101(35):e30183. PubMed ID: 36107564
[TBL] [Abstract][Full Text] [Related]
14. Paediatric supratentorial tumours do not cause microstructural alterations in contralateral white matter: a preliminary study.
Genç B; Delibalta S; Aslan K; Ceyhan Bilgici MN
Childs Nerv Syst; 2024 Jan; 40(1):41-46. PubMed ID: 37470834
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of brain perfusion with ASL and DSC MRI following intracranial vascular flow diverter stent replacement.
Kaydu NE; Cindil E; Asfuroglu BB; Onal B; Oner AY
J Clin Ultrasound; 2023 Oct; 51(8):1390-1396. PubMed ID: 37530531
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of pilocytic astrocytoma, medulloblastoma, and hemangioblastoma on diffusion-weighted and dynamic susceptibility contrast perfusion MRI.
Kurokawa R; Kurokawa M; Baba A; Kim J; Capizzano A; Bapuraj J; Srinivasan A; Moritani T
Medicine (Baltimore); 2022 Nov; 101(44):e31708. PubMed ID: 36343086
[TBL] [Abstract][Full Text] [Related]
17. Assessing the added value of apparent diffusion coefficient, cerebral blood volume, and radiomic magnetic resonance features for differentiation of pseudoprogression versus true tumor progression in patients with glioblastoma.
Leone R; Meredig H; Foltyn-Dumitru M; Sahm F; Hamelmann S; Kurz F; Kessler T; Bonekamp D; Schlemmer HP; Bo Hansen M; Wick W; Bendszus M; Vollmuth P; Brugnara G
Neurooncol Adv; 2023; 5(1):vdad016. PubMed ID: 36968291
[TBL] [Abstract][Full Text] [Related]
18. Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma.
Jabehdar Maralani P; Stewart J; Hiremath S; Lawrence L; Chan R; Lau A; Chen H; Chan A; Zeng LK; Tseng CL; Myrehaug S; Soliman H; Detsky J; Heyn C; Lim Fat M; Lipsman N; Sahgal A
J Neurooncol; 2023 Sep; 164(3):597-605. PubMed ID: 37707752
[TBL] [Abstract][Full Text] [Related]
19. The Role of Apparent Diffusion Coefficient Values in Glioblastoma: Differentiating Tumor Progression Versus Treatment-Related Changes.
Kamali A; Gandhi A; Nunez LC; Lugo AE; Arevalo-Espejo O; Zhu JJ; Esquenazi-Levy Y; Zhang X; Riascos RF
J Comput Assist Tomogr; 2022 Nov-Dec 01; 46(6):923-928. PubMed ID: 36112011
[TBL] [Abstract][Full Text] [Related]
20. Peritumoral ADC Values Correlate with the MGMT Methylation Status in Patients with Glioblastoma.
Ladenhauf VK; Galijasevic M; Kerschbaumer J; Freyschlag CF; Nowosielski M; Birkl-Toeglhofer AM; Haybaeck J; Gizewski ER; Mangesius S; Grams AE
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
